SlideShare a Scribd company logo
1 of 37
Download to read offline
Inflammation
and Repair - 5

  Dr.CSBR.Prasad, M.D.



       v3-CSBRP-May-2012
Sequence of events in
        Inflammation
Vascular                     Cellular
• Vasodilation               • Margination
• Increased vascular         • Rolling
  permeability               • Adhesion
                             • Diapedesis
                             • Chemotaxis
                             • Phagocytosis
                             • Killing & degradation

                   v3-CSBRP-May-2012
Events are reflected clinically by
 Cardinal signs of inflammation

            •    Rubor
            •    Calor
            •    Dolar
            •    Tumor
            •    Loss of function



                v3-CSBRP-May-2012
Chemical Mediators
 of Inflammation


      v3-CSBRP-May-2012
Chemical Mediators

Def: Any messenger that acts on blood
 vessels, leucocytes, or other cells to
 contribute to an inflammatory response




               v3-CSBRP-May-2012
Chemical Mediators

• Vasodilation
  – Prostaglandins, Nitric Oxide
• Increased Vascular Permeability
  – Vasoactive amines (histamine, serotonin),
    C3a and C5a, Bradykinin, Leukotrienes, PAF
• Chemotaxic Leukocyte Activation
  – C5a, LTB4, Chemokines


                  v3-CSBRP-May-2012
Chemical Mediators
 • Fever
   – IL-1, IL-6, TNF, PGE2
 • Pain
   – Prostaglandins, Bradykinin
 • Tissue Damage
   – Neutrophil and Macrophage products
     – Lysosomal enzymes
     – Oxygen metabolites
     – NO

           v3-CSBRP-May-2012
Chemical Mediators
General properties:

• They are generated from:
     Cells
     Plasma proteins

• Mediators are produced in response to various stimuli

• One mediator can stimulate the release of other
  [Guarantees amplification and maintenance of inflammatory response]

• Mediators vary in their range of cellular targets

• Majority are short-lived [Short t ½ and are harmful]
                           v3-CSBRP-May-2012
v3-CSBRP-May-2012
Cell derived mediators
   Vasoactive Amines: Histamine and Serotonin
   AA Metabolites: PGs, LTs, and Lipoxins
   Platelet-Activating Factor (PAF)
   ROS
   Nitric Oxide (NO)
   Cytokines and Chemokines
   Tumor Necrosis Factor and Interleukin-1
   Chemokines
   Other Cytokines IL6, IL17
   Lysosomal Constituents of Leukocytes
   Neuropeptides
                       v3-CSBRP-May-2012
Plasma derived mediators
    PLASMA PROTEASES
3 interrelated systems are active within this category

             1. Kinin system
                   Highly vasoactive
             2. Complement system
                   Vasoactive
                   Chemotactic
             3. Clotting system
                   Vasoactive
                   Cleaves C3

                    v3-CSBRP-May-2012
Cell derived mediators
   Vasoactive Amines: Histamine and Serotonin
   AA Metabolites: PGs, LTs, and Lipoxins
   Platelet-Activating Factor (PAF)
   ROS
   Nitric Oxide (NO)
   Cytokines and Chemokines
   Tumor Necrosis Factor and Interleukin-1
   Chemokines
   Other Cytokines IL6, IL17
   Lysosomal Constituents of Leukocytes
   Neuropeptides
                       v3-CSBRP-May-2012
Cell derived mediators
Vasoactive Amines: Histamine and Serotonin
• Increase Vascular Permeability
• Histamine and Serotonin
   Mediators in the immediate active phase of
   increased permeability
    – Promotes contraction of smooth muscle
    – Stimulates to cells to produce eotaxins



                    v3-CSBRP-May-2012
Cell derived mediators
Vasoactive Amines: Histamine and Serotonin
• Releasing Stimulators
  – Direct physical or chemical injury
  – Binding of IgE- Ag- complexes
  – Fragments of C3a and C5a
  – Histamine releasing factors (pmn’s and θ)
  – Cytokines (IL-1, IL-8)
  – Neuropeptides

                   v3-CSBRP-May-2012
ARACHIDONIC ACID
              METABOLITES
• Roles in many biologic and           • Via activation of cellular
  pathologic processes                   phospholipases
   – Inflammation                              – By mechanical, chemical
• 20-carbon polyunsaturated                      and physical stimuli or by
                                                 other mediators
  fatty acid
   – Derived directly from dietary     • 2 major pathways
     sources or by conversion of               – Cyclooxygenase pathway
     essential fatty acid linoleic             – Lipoxygenase pathway.
     acid
• Esterified in membrane
  phospholipids
   – Must first be released from
     phospholipids

                           v3-CSBRP-May-2012
v3-CSBRP-May-2012
CYCLOOXYGENASE PATHWAY
• 2 cyclooxygenase enzymes
  – COX-1
  – COX-2
• 3 important products
  – Thromboxane A2
    – Aggregates platelets and causes vasoconstriction
  – Prostacyclin (PGI2)
    – Endothelial cells inhibits platelet aggregation and causes
      vasodilation
  – Prostaglandins PGE2, PGF2 and PGD2
    – Variety of actions on vascular tone and permeability

                        v3-CSBRP-May-2012
LIPOXYGENASE PATHWAY
Leukotrienes - LT
• LT B4 is a potent chemotactic agent
• Leukotrienes C4, D4, E4
  – Potent vasoconstrictors
  – Potent mediators of increased vascular
    permeability on venules only
  – Up to 1000 times as potent as histamine in
    producing increased vascular permeability

                   v3-CSBRP-May-2012
NOTE:
 Some anti-inflammatory drugs interfere
  with arachidonic acid metabolism
   – Corticosteroids interfere with phospholipase
   – Aspirin interferes with cyclooxygenase




                   v3-CSBRP-May-2012
PLATELET ACTIVATING
           FACTOR - PAF

•   Aggregate platelets and cause release
•   Bronchoconstriction and Vasoconstriction
•   ↑ vascular permeability
•   ↑ leukocyte adhesion
•   Leukocyte chemotaxis



                   v3-CSBRP-May-2012
CYTOKINES

• Transmitters for cell-to-cell chatting
  – Modulate cell function
• Primarily from activated macrophages and
  lymphocytes
• IL-1, IL-8, TNF




                   v3-CSBRP-May-2012
IL-I and TNF
“Master Cytokines”
• Origin
    – Monocytes
    – Macrophages
•   Similar in action
•   Endothelium
•   Acute phase proteins
•   Fibroblasts
       v3-CSBRP-May-2012
v3-CSBRP-May-2012
Other Cytokines
• IL-5
  – Eosinophils
• IL-6
  – B and T cells
• IL-8
  – Neutrophils
  – Lesser degree monocytes and eosinophils


                    v3-CSBRP-May-2012
GROWTH FACTORS
• Platelet derived growth factor - PGDF
• Transforming growth factor β
  – Chemokines
          - Leukocytes and Mesenchymal Cells

• Important in regeneration and repair




                    v3-CSBRP-May-2012
LYSOSOMAL CONSTITUENTS
• Neutrophils, Monocyte/Macrophages
  – Enzymes and proteins within granules
• Cationic proteins
  – ↑ vascular permeability
  – Chemotactic
• Neutral proteases
  – Degrade ECM


                   v3-CSBRP-May-2012
Plasma derived mediators
    PLASMA PROTEASES
 3 interrelated systems are active within this category

              1. Kinin system
                    Highly vasoactive
              2. Complement system
                    Vasoactive
                    Chemotactic
              3. Clotting system
                    Vasoactive
                    Cleaves C3

                     v3-CSBRP-May-2012
v3-CSBRP-May-2012
BRADYKININ
• Released by activated Hageman factor (XIIa)
• Bradykinin
    • Release of vasoactive nonapeptide bradykinin
    • Generated from the plasma HMWK
•   Potent vasodilator
•   Increased vascular permeability
•   Contraction of smooth muscle            PAIN
•   Produce pain
•   Stimulates release of histamine
•   Activates the arachidonic acid cascade

                       v3-CSBRP-May-2012
IMPORTANT NOTE
Activated Hageman factor (factor XIIA)
 initiates the clotting, fibrinolytic and kinin
 systems
The products of this initiation (kallikrein,
 factor XIIA, and plasmin, but particularly,
 kallikrein) can, by feedback, activate
 Hageman factor, resulting in significant
 amplification of the effects of the initial
 stimulus
                   v3-CSBRP-May-2012
Complement system
• Plasma proteins - act against microbial
  agents
• Products of activated complement
  – Vascular permeability
  – Chemotaxis
  – Opsonization
  – Lysis


                  v3-CSBRP-May-2012
v3-CSBRP-May-2012
v3-CSBRP-May-2012
v3-CSBRP-May-2012
v3-CSBRP-May-2012
END


v3-CSBRP-May-2012
v3-CSBRP-May-2012

More Related Content

What's hot

Acute And Chronic Inflammation
Acute And Chronic InflammationAcute And Chronic Inflammation
Acute And Chronic Inflammationaxix
 
Inflammation....
Inflammation....Inflammation....
Inflammation....ANIL KUMAR
 
INFLAMMATION AND INJURY - Lecture 2
INFLAMMATION AND INJURY - Lecture 2INFLAMMATION AND INJURY - Lecture 2
INFLAMMATION AND INJURY - Lecture 2Dr. Roopam Jain
 
11 cellular & vascular events in acute inflammation
11 cellular & vascular events in acute inflammation11 cellular & vascular events in acute inflammation
11 cellular & vascular events in acute inflammationDr UAK
 
Pathology healing and repair stmu
Pathology healing and repair stmuPathology healing and repair stmu
Pathology healing and repair stmumuhammad shoaib
 
Chronic inflammation 2-1-2
Chronic inflammation 2-1-2Chronic inflammation 2-1-2
Chronic inflammation 2-1-2Nimra Iqbal
 
mediators of inflammation
mediators of inflammationmediators of inflammation
mediators of inflammationMehul Shinde
 
Inflammation and repair darpan
Inflammation and repair darpanInflammation and repair darpan
Inflammation and repair darpanDarpan Nenava
 
Mechanism involved in the process of inflammation lecture 5
Mechanism involved in the process of inflammation  lecture 5Mechanism involved in the process of inflammation  lecture 5
Mechanism involved in the process of inflammation lecture 5Archana Mandava
 
Lab diagnosis,investigations of pulmonary tuberculosis
Lab diagnosis,investigations of pulmonary tuberculosisLab diagnosis,investigations of pulmonary tuberculosis
Lab diagnosis,investigations of pulmonary tuberculosisYasminBanuShabeekMoh
 
INFLAMMATION PATHOPHYSIOLOGY
INFLAMMATION PATHOPHYSIOLOGYINFLAMMATION PATHOPHYSIOLOGY
INFLAMMATION PATHOPHYSIOLOGYDAWN V TOMY
 
Healing and repair
Healing and repair Healing and repair
Healing and repair dinesh
 
CHEMICAL MEDIATORS OF INFLAMMATION CLASS- 02
CHEMICAL MEDIATORS OF INFLAMMATION CLASS- 02CHEMICAL MEDIATORS OF INFLAMMATION CLASS- 02
CHEMICAL MEDIATORS OF INFLAMMATION CLASS- 02anandabhishek912
 
Acute inflammation(pathology)
Acute inflammation(pathology)Acute inflammation(pathology)
Acute inflammation(pathology)Muhammad Bilal
 
Inflammation
InflammationInflammation
Inflammationdentist
 

What's hot (20)

Inflammation
InflammationInflammation
Inflammation
 
Acute And Chronic Inflammation
Acute And Chronic InflammationAcute And Chronic Inflammation
Acute And Chronic Inflammation
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
Inflammation....
Inflammation....Inflammation....
Inflammation....
 
acute inflammation
acute inflammationacute inflammation
acute inflammation
 
INFLAMMATION AND INJURY - Lecture 2
INFLAMMATION AND INJURY - Lecture 2INFLAMMATION AND INJURY - Lecture 2
INFLAMMATION AND INJURY - Lecture 2
 
11 cellular & vascular events in acute inflammation
11 cellular & vascular events in acute inflammation11 cellular & vascular events in acute inflammation
11 cellular & vascular events in acute inflammation
 
Pathology healing and repair stmu
Pathology healing and repair stmuPathology healing and repair stmu
Pathology healing and repair stmu
 
Inflammation
InflammationInflammation
Inflammation
 
Chronic inflammation 2-1-2
Chronic inflammation 2-1-2Chronic inflammation 2-1-2
Chronic inflammation 2-1-2
 
mediators of inflammation
mediators of inflammationmediators of inflammation
mediators of inflammation
 
Inflammation and repair darpan
Inflammation and repair darpanInflammation and repair darpan
Inflammation and repair darpan
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
Mechanism involved in the process of inflammation lecture 5
Mechanism involved in the process of inflammation  lecture 5Mechanism involved in the process of inflammation  lecture 5
Mechanism involved in the process of inflammation lecture 5
 
Lab diagnosis,investigations of pulmonary tuberculosis
Lab diagnosis,investigations of pulmonary tuberculosisLab diagnosis,investigations of pulmonary tuberculosis
Lab diagnosis,investigations of pulmonary tuberculosis
 
INFLAMMATION PATHOPHYSIOLOGY
INFLAMMATION PATHOPHYSIOLOGYINFLAMMATION PATHOPHYSIOLOGY
INFLAMMATION PATHOPHYSIOLOGY
 
Healing and repair
Healing and repair Healing and repair
Healing and repair
 
CHEMICAL MEDIATORS OF INFLAMMATION CLASS- 02
CHEMICAL MEDIATORS OF INFLAMMATION CLASS- 02CHEMICAL MEDIATORS OF INFLAMMATION CLASS- 02
CHEMICAL MEDIATORS OF INFLAMMATION CLASS- 02
 
Acute inflammation(pathology)
Acute inflammation(pathology)Acute inflammation(pathology)
Acute inflammation(pathology)
 
Inflammation
InflammationInflammation
Inflammation
 

Viewers also liked

Pulmonary Hypertension
Pulmonary HypertensionPulmonary Hypertension
Pulmonary HypertensionPrasad CSBR
 
RBC Disorders - case studies
RBC Disorders - case studiesRBC Disorders - case studies
RBC Disorders - case studiesPrasad CSBR
 
Asbestos&Berylliosis
Asbestos&BerylliosisAsbestos&Berylliosis
Asbestos&BerylliosisPrasad CSBR
 
Carcinoma - Lung
Carcinoma - LungCarcinoma - Lung
Carcinoma - LungPrasad CSBR
 
Paraneoplastic syndromes
Paraneoplastic syndromesParaneoplastic syndromes
Paraneoplastic syndromesPrasad CSBR
 
Diseases of the Pleura
Diseases of the PleuraDiseases of the Pleura
Diseases of the PleuraPrasad CSBR
 
Histamine & bradykinin
Histamine & bradykininHistamine & bradykinin
Histamine & bradykininankit
 
Chronic bronchitis
Chronic bronchitisChronic bronchitis
Chronic bronchitisPrasad CSBR
 
Pulmonary Infections
Pulmonary InfectionsPulmonary Infections
Pulmonary InfectionsPrasad CSBR
 

Viewers also liked (20)

Inflammation 4
Inflammation 4Inflammation 4
Inflammation 4
 
Inflammation 9
Inflammation 9Inflammation 9
Inflammation 9
 
Pulmonary Hypertension
Pulmonary HypertensionPulmonary Hypertension
Pulmonary Hypertension
 
Coin lesion
Coin lesionCoin lesion
Coin lesion
 
Inflammation 8
Inflammation 8Inflammation 8
Inflammation 8
 
Inflammation 6
Inflammation 6Inflammation 6
Inflammation 6
 
Inflammation 7
Inflammation 7Inflammation 7
Inflammation 7
 
RBC Disorders - case studies
RBC Disorders - case studiesRBC Disorders - case studies
RBC Disorders - case studies
 
Inflammation 2
Inflammation 2Inflammation 2
Inflammation 2
 
Asbestos&Berylliosis
Asbestos&BerylliosisAsbestos&Berylliosis
Asbestos&Berylliosis
 
Carcinoma - Lung
Carcinoma - LungCarcinoma - Lung
Carcinoma - Lung
 
Bronchiectasis
BronchiectasisBronchiectasis
Bronchiectasis
 
Paraneoplastic syndromes
Paraneoplastic syndromesParaneoplastic syndromes
Paraneoplastic syndromes
 
Diseases of the Pleura
Diseases of the PleuraDiseases of the Pleura
Diseases of the Pleura
 
Histamine & bradykinin
Histamine & bradykininHistamine & bradykinin
Histamine & bradykinin
 
Rbc disorders 1
Rbc disorders 1Rbc disorders 1
Rbc disorders 1
 
Chronic bronchitis
Chronic bronchitisChronic bronchitis
Chronic bronchitis
 
Pulmonary Infections
Pulmonary InfectionsPulmonary Infections
Pulmonary Infections
 
Emphysema
EmphysemaEmphysema
Emphysema
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 

Similar to Inflammation 5

Chemical_mediators_of_inflammation.pptx
Chemical_mediators_of_inflammation.pptxChemical_mediators_of_inflammation.pptx
Chemical_mediators_of_inflammation.pptxsujjiflower
 
Chemical mediator of inflammation
Chemical mediator of inflammationChemical mediator of inflammation
Chemical mediator of inflammationLakshmiNaveen1
 
Ritik Pilania (chemical mediators).pptx
Ritik Pilania (chemical mediators).pptxRitik Pilania (chemical mediators).pptx
Ritik Pilania (chemical mediators).pptxHONEYKID
 
Ritik Pilania (chemical mediators).pptx
Ritik Pilania (chemical mediators).pptxRitik Pilania (chemical mediators).pptx
Ritik Pilania (chemical mediators).pptxHONEYKID
 
Chemical mediators of inflammation
Chemical mediators of inflammationChemical mediators of inflammation
Chemical mediators of inflammationAiswarya Thomas
 
Inflamation ppt
Inflamation pptInflamation ppt
Inflamation pptSrota Dawn
 
Inflammation dr. ihsan alsaimary
Inflammation dr. ihsan alsaimaryInflammation dr. ihsan alsaimary
Inflammation dr. ihsan alsaimarydr.Ihsan alsaimary
 
lecture6- inflam 2013 aaaaaaaaaaaaaa.ppt
lecture6- inflam 2013 aaaaaaaaaaaaaa.pptlecture6- inflam 2013 aaaaaaaaaaaaaa.ppt
lecture6- inflam 2013 aaaaaaaaaaaaaa.pptShahid594898
 
chemical mediators AHS cls.pptx
chemical mediators AHS cls.pptxchemical mediators AHS cls.pptx
chemical mediators AHS cls.pptxManjula N
 
chemical mediators AHS cls.pptx
chemical mediators AHS cls.pptxchemical mediators AHS cls.pptx
chemical mediators AHS cls.pptxManjula N
 
Chemical mediators of inflammation
Chemical mediators of inflammationChemical mediators of inflammation
Chemical mediators of inflammationpreetiagrawal79
 
Inflammation healing and repair seminar - DR. SAUMYA PAUL
Inflammation healing and repair seminar - DR. SAUMYA PAULInflammation healing and repair seminar - DR. SAUMYA PAUL
Inflammation healing and repair seminar - DR. SAUMYA PAULSAUMYA PAUL
 
Infamattion in dentistry (dept of public health dentistry )
Infamattion in dentistry (dept of public health dentistry )Infamattion in dentistry (dept of public health dentistry )
Infamattion in dentistry (dept of public health dentistry )NPDCH VISNAGAR
 

Similar to Inflammation 5 (20)

Chemical_mediators_of_inflammation.pptx
Chemical_mediators_of_inflammation.pptxChemical_mediators_of_inflammation.pptx
Chemical_mediators_of_inflammation.pptx
 
Chemical mediator of inflammation
Chemical mediator of inflammationChemical mediator of inflammation
Chemical mediator of inflammation
 
Ritik Pilania (chemical mediators).pptx
Ritik Pilania (chemical mediators).pptxRitik Pilania (chemical mediators).pptx
Ritik Pilania (chemical mediators).pptx
 
Ritik Pilania (chemical mediators).pptx
Ritik Pilania (chemical mediators).pptxRitik Pilania (chemical mediators).pptx
Ritik Pilania (chemical mediators).pptx
 
Chemical mediators of inflammation
Chemical mediators of inflammationChemical mediators of inflammation
Chemical mediators of inflammation
 
Inflamation ppt
Inflamation pptInflamation ppt
Inflamation ppt
 
Chemical mediators of inflammation
Chemical mediators of inflammationChemical mediators of inflammation
Chemical mediators of inflammation
 
Mediators of inflammation
Mediators of inflammationMediators of inflammation
Mediators of inflammation
 
Inflammation dr. ihsan alsaimary
Inflammation dr. ihsan alsaimaryInflammation dr. ihsan alsaimary
Inflammation dr. ihsan alsaimary
 
lecture6- inflam 2013 aaaaaaaaaaaaaa.ppt
lecture6- inflam 2013 aaaaaaaaaaaaaa.pptlecture6- inflam 2013 aaaaaaaaaaaaaa.ppt
lecture6- inflam 2013 aaaaaaaaaaaaaa.ppt
 
chemical mediators AHS cls.pptx
chemical mediators AHS cls.pptxchemical mediators AHS cls.pptx
chemical mediators AHS cls.pptx
 
chemical mediators AHS cls.pptx
chemical mediators AHS cls.pptxchemical mediators AHS cls.pptx
chemical mediators AHS cls.pptx
 
Chemical mediators of inflammation
Chemical mediators of inflammationChemical mediators of inflammation
Chemical mediators of inflammation
 
enz clini.ppt
enz clini.pptenz clini.ppt
enz clini.ppt
 
Blood
BloodBlood
Blood
 
IVMS-Gen Path-Inflammation
IVMS-Gen Path-InflammationIVMS-Gen Path-Inflammation
IVMS-Gen Path-Inflammation
 
Blood and Its Components
Blood and Its Components Blood and Its Components
Blood and Its Components
 
Blood
Blood Blood
Blood
 
Inflammation healing and repair seminar - DR. SAUMYA PAUL
Inflammation healing and repair seminar - DR. SAUMYA PAULInflammation healing and repair seminar - DR. SAUMYA PAUL
Inflammation healing and repair seminar - DR. SAUMYA PAUL
 
Infamattion in dentistry (dept of public health dentistry )
Infamattion in dentistry (dept of public health dentistry )Infamattion in dentistry (dept of public health dentistry )
Infamattion in dentistry (dept of public health dentistry )
 

More from Prasad CSBR

Acute leukemias aml-csbrp
Acute leukemias aml-csbrpAcute leukemias aml-csbrp
Acute leukemias aml-csbrpPrasad CSBR
 
Case stuies in Lymphomas
Case stuies in LymphomasCase stuies in Lymphomas
Case stuies in LymphomasPrasad CSBR
 
Case studies in inflammation-1
Case studies in inflammation-1Case studies in inflammation-1
Case studies in inflammation-1Prasad CSBR
 
Invasion &; metastasis csbrp
Invasion &; metastasis csbrpInvasion &; metastasis csbrp
Invasion &; metastasis csbrpPrasad CSBR
 
Neoplasia introduction
Neoplasia introductionNeoplasia introduction
Neoplasia introductionPrasad CSBR
 
Chemical safety
Chemical safety  Chemical safety
Chemical safety Prasad CSBR
 
Single genedisorders 1
Single genedisorders 1Single genedisorders 1
Single genedisorders 1Prasad CSBR
 
Leucocyte Disorders - Case studies
Leucocyte Disorders - Case studiesLeucocyte Disorders - Case studies
Leucocyte Disorders - Case studiesPrasad CSBR
 
Approach to endometrial biopsy
Approach to endometrial biopsyApproach to endometrial biopsy
Approach to endometrial biopsyPrasad CSBR
 
Cell injuryadaptation 7
Cell injuryadaptation 7Cell injuryadaptation 7
Cell injuryadaptation 7Prasad CSBR
 
Cell injuryadaptation 6
Cell injuryadaptation 6Cell injuryadaptation 6
Cell injuryadaptation 6Prasad CSBR
 
Cell injuryadaptation 5
Cell injuryadaptation 5Cell injuryadaptation 5
Cell injuryadaptation 5Prasad CSBR
 
Cell injuryadaptation 4
Cell injuryadaptation 4Cell injuryadaptation 4
Cell injuryadaptation 4Prasad CSBR
 
Cell injuryadaptation 3
Cell injuryadaptation 3Cell injuryadaptation 3
Cell injuryadaptation 3Prasad CSBR
 
Cell injuryadaptation 2
Cell injuryadaptation 2Cell injuryadaptation 2
Cell injuryadaptation 2Prasad CSBR
 
Cell injuryadaptation 1
Cell injuryadaptation 1Cell injuryadaptation 1
Cell injuryadaptation 1Prasad CSBR
 

More from Prasad CSBR (20)

Acute leukemias aml-csbrp
Acute leukemias aml-csbrpAcute leukemias aml-csbrp
Acute leukemias aml-csbrp
 
Case stuies in Lymphomas
Case stuies in LymphomasCase stuies in Lymphomas
Case stuies in Lymphomas
 
Case studies in inflammation-1
Case studies in inflammation-1Case studies in inflammation-1
Case studies in inflammation-1
 
Invasion &; metastasis csbrp
Invasion &; metastasis csbrpInvasion &; metastasis csbrp
Invasion &; metastasis csbrp
 
Neoplasia introduction
Neoplasia introductionNeoplasia introduction
Neoplasia introduction
 
Chemical safety
Chemical safety  Chemical safety
Chemical safety
 
Single genedisorders 1
Single genedisorders 1Single genedisorders 1
Single genedisorders 1
 
Leucocyte Disorders - Case studies
Leucocyte Disorders - Case studiesLeucocyte Disorders - Case studies
Leucocyte Disorders - Case studies
 
Approach to endometrial biopsy
Approach to endometrial biopsyApproach to endometrial biopsy
Approach to endometrial biopsy
 
Vit a-csbrp
Vit a-csbrpVit a-csbrp
Vit a-csbrp
 
Cell injuryadaptation 7
Cell injuryadaptation 7Cell injuryadaptation 7
Cell injuryadaptation 7
 
Cell injuryadaptation 6
Cell injuryadaptation 6Cell injuryadaptation 6
Cell injuryadaptation 6
 
Cell injuryadaptation 5
Cell injuryadaptation 5Cell injuryadaptation 5
Cell injuryadaptation 5
 
Cell injuryadaptation 4
Cell injuryadaptation 4Cell injuryadaptation 4
Cell injuryadaptation 4
 
Cell injuryadaptation 3
Cell injuryadaptation 3Cell injuryadaptation 3
Cell injuryadaptation 3
 
Cell injuryadaptation 2
Cell injuryadaptation 2Cell injuryadaptation 2
Cell injuryadaptation 2
 
Cell injuryadaptation 1
Cell injuryadaptation 1Cell injuryadaptation 1
Cell injuryadaptation 1
 
7 shock
7 shock7 shock
7 shock
 
6 infarction
6 infarction6 infarction
6 infarction
 
5 embolism
5 embolism5 embolism
5 embolism
 

Recently uploaded

Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Victor Rentea
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobeapidays
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamUiPathCommunity
 
Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Zilliz
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...apidays
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistandanishmna97
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusZilliz
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfsudhanshuwaghmare1
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfOrbitshub
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodJuan lago vázquez
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...apidays
 
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelMcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelDeepika Singh
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Orbitshub
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MIND CTI
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsNanddeep Nachan
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Angeliki Cooney
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
Vector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxVector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxRemote DBA Services
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 

Recently uploaded (20)

Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
 
Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
 
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelMcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectors
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Vector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxVector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptx
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 

Inflammation 5

  • 1. Inflammation and Repair - 5 Dr.CSBR.Prasad, M.D. v3-CSBRP-May-2012
  • 2. Sequence of events in Inflammation Vascular Cellular • Vasodilation • Margination • Increased vascular • Rolling permeability • Adhesion • Diapedesis • Chemotaxis • Phagocytosis • Killing & degradation v3-CSBRP-May-2012
  • 3. Events are reflected clinically by Cardinal signs of inflammation • Rubor • Calor • Dolar • Tumor • Loss of function v3-CSBRP-May-2012
  • 4. Chemical Mediators of Inflammation v3-CSBRP-May-2012
  • 5. Chemical Mediators Def: Any messenger that acts on blood vessels, leucocytes, or other cells to contribute to an inflammatory response v3-CSBRP-May-2012
  • 6. Chemical Mediators • Vasodilation – Prostaglandins, Nitric Oxide • Increased Vascular Permeability – Vasoactive amines (histamine, serotonin), C3a and C5a, Bradykinin, Leukotrienes, PAF • Chemotaxic Leukocyte Activation – C5a, LTB4, Chemokines v3-CSBRP-May-2012
  • 7. Chemical Mediators • Fever – IL-1, IL-6, TNF, PGE2 • Pain – Prostaglandins, Bradykinin • Tissue Damage – Neutrophil and Macrophage products – Lysosomal enzymes – Oxygen metabolites – NO v3-CSBRP-May-2012
  • 8. Chemical Mediators General properties: • They are generated from: Cells Plasma proteins • Mediators are produced in response to various stimuli • One mediator can stimulate the release of other [Guarantees amplification and maintenance of inflammatory response] • Mediators vary in their range of cellular targets • Majority are short-lived [Short t ½ and are harmful] v3-CSBRP-May-2012
  • 10. Cell derived mediators  Vasoactive Amines: Histamine and Serotonin  AA Metabolites: PGs, LTs, and Lipoxins  Platelet-Activating Factor (PAF)  ROS  Nitric Oxide (NO)  Cytokines and Chemokines  Tumor Necrosis Factor and Interleukin-1  Chemokines  Other Cytokines IL6, IL17  Lysosomal Constituents of Leukocytes  Neuropeptides v3-CSBRP-May-2012
  • 11. Plasma derived mediators PLASMA PROTEASES 3 interrelated systems are active within this category 1. Kinin system Highly vasoactive 2. Complement system Vasoactive Chemotactic 3. Clotting system Vasoactive Cleaves C3 v3-CSBRP-May-2012
  • 12. Cell derived mediators  Vasoactive Amines: Histamine and Serotonin  AA Metabolites: PGs, LTs, and Lipoxins  Platelet-Activating Factor (PAF)  ROS  Nitric Oxide (NO)  Cytokines and Chemokines  Tumor Necrosis Factor and Interleukin-1  Chemokines  Other Cytokines IL6, IL17  Lysosomal Constituents of Leukocytes  Neuropeptides v3-CSBRP-May-2012
  • 13. Cell derived mediators Vasoactive Amines: Histamine and Serotonin • Increase Vascular Permeability • Histamine and Serotonin Mediators in the immediate active phase of increased permeability – Promotes contraction of smooth muscle – Stimulates to cells to produce eotaxins v3-CSBRP-May-2012
  • 14. Cell derived mediators Vasoactive Amines: Histamine and Serotonin • Releasing Stimulators – Direct physical or chemical injury – Binding of IgE- Ag- complexes – Fragments of C3a and C5a – Histamine releasing factors (pmn’s and θ) – Cytokines (IL-1, IL-8) – Neuropeptides v3-CSBRP-May-2012
  • 15. ARACHIDONIC ACID METABOLITES • Roles in many biologic and • Via activation of cellular pathologic processes phospholipases – Inflammation – By mechanical, chemical • 20-carbon polyunsaturated and physical stimuli or by other mediators fatty acid – Derived directly from dietary • 2 major pathways sources or by conversion of – Cyclooxygenase pathway essential fatty acid linoleic – Lipoxygenase pathway. acid • Esterified in membrane phospholipids – Must first be released from phospholipids v3-CSBRP-May-2012
  • 17. CYCLOOXYGENASE PATHWAY • 2 cyclooxygenase enzymes – COX-1 – COX-2 • 3 important products – Thromboxane A2 – Aggregates platelets and causes vasoconstriction – Prostacyclin (PGI2) – Endothelial cells inhibits platelet aggregation and causes vasodilation – Prostaglandins PGE2, PGF2 and PGD2 – Variety of actions on vascular tone and permeability v3-CSBRP-May-2012
  • 18. LIPOXYGENASE PATHWAY Leukotrienes - LT • LT B4 is a potent chemotactic agent • Leukotrienes C4, D4, E4 – Potent vasoconstrictors – Potent mediators of increased vascular permeability on venules only – Up to 1000 times as potent as histamine in producing increased vascular permeability v3-CSBRP-May-2012
  • 19. NOTE: Some anti-inflammatory drugs interfere with arachidonic acid metabolism – Corticosteroids interfere with phospholipase – Aspirin interferes with cyclooxygenase v3-CSBRP-May-2012
  • 20. PLATELET ACTIVATING FACTOR - PAF • Aggregate platelets and cause release • Bronchoconstriction and Vasoconstriction • ↑ vascular permeability • ↑ leukocyte adhesion • Leukocyte chemotaxis v3-CSBRP-May-2012
  • 21. CYTOKINES • Transmitters for cell-to-cell chatting – Modulate cell function • Primarily from activated macrophages and lymphocytes • IL-1, IL-8, TNF v3-CSBRP-May-2012
  • 22. IL-I and TNF “Master Cytokines” • Origin – Monocytes – Macrophages • Similar in action • Endothelium • Acute phase proteins • Fibroblasts v3-CSBRP-May-2012
  • 24. Other Cytokines • IL-5 – Eosinophils • IL-6 – B and T cells • IL-8 – Neutrophils – Lesser degree monocytes and eosinophils v3-CSBRP-May-2012
  • 25. GROWTH FACTORS • Platelet derived growth factor - PGDF • Transforming growth factor β – Chemokines - Leukocytes and Mesenchymal Cells • Important in regeneration and repair v3-CSBRP-May-2012
  • 26. LYSOSOMAL CONSTITUENTS • Neutrophils, Monocyte/Macrophages – Enzymes and proteins within granules • Cationic proteins – ↑ vascular permeability – Chemotactic • Neutral proteases – Degrade ECM v3-CSBRP-May-2012
  • 27. Plasma derived mediators PLASMA PROTEASES 3 interrelated systems are active within this category 1. Kinin system Highly vasoactive 2. Complement system Vasoactive Chemotactic 3. Clotting system Vasoactive Cleaves C3 v3-CSBRP-May-2012
  • 29. BRADYKININ • Released by activated Hageman factor (XIIa) • Bradykinin • Release of vasoactive nonapeptide bradykinin • Generated from the plasma HMWK • Potent vasodilator • Increased vascular permeability • Contraction of smooth muscle PAIN • Produce pain • Stimulates release of histamine • Activates the arachidonic acid cascade v3-CSBRP-May-2012
  • 30. IMPORTANT NOTE Activated Hageman factor (factor XIIA) initiates the clotting, fibrinolytic and kinin systems The products of this initiation (kallikrein, factor XIIA, and plasmin, but particularly, kallikrein) can, by feedback, activate Hageman factor, resulting in significant amplification of the effects of the initial stimulus v3-CSBRP-May-2012
  • 31. Complement system • Plasma proteins - act against microbial agents • Products of activated complement – Vascular permeability – Chemotaxis – Opsonization – Lysis v3-CSBRP-May-2012